ID   ERAP2_HUMAN             Reviewed;         960 AA.
AC   Q6P179; Q7Z5K1; Q8TD32; Q8WVJ4; Q9HBX2;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   07-JAN-2015, entry version 99.
DE   RecName: Full=Endoplasmic reticulum aminopeptidase 2;
DE            EC=3.4.11.-;
DE   AltName: Full=Leukocyte-derived arginine aminopeptidase;
DE            Short=L-RAP;
GN   Name=ERAP2; Synonyms=LRAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME ACTIVITY,
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, TOPOLOGY, TISSUE SPECIFICITY, AND
RP   VARIANT ASN-392.
RX   PubMed=12799365; DOI=10.1074/jbc.M305076200;
RA   Tanioka T., Hattori A., Masuda S., Nomura Y., Nakayama H.,
RA   Mizutani S., Tsujimoto M.;
RT   "Human leukocyte-derived arginine aminopeptidase. The third member of
RT   the oxytocinase subfamily of aminopeptidases.";
RL   J. Biol. Chem. 278:32275-32283(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INDUCTION BY IFNG, AND VARIANT
RP   ASN-392.
RX   PubMed=15691326; DOI=10.1111/j.1742-4658.2004.04521.x;
RA   Tanioka T., Hattori A., Mizutani S., Tsujimoto M.;
RT   "Regulation of the human leukocyte-derived arginine
RT   aminopeptidase/endoplasmic reticulum-aminopeptidase 2 gene by
RT   interferon-gamma.";
RL   FEBS J. 272:916-928(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Schomburg L.;
RT   "Molecular characterization of aminopeptidase MAMS.";
RL   Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Skeletal muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-119.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [7]
RP   FUNCTION, SUBUNIT, AND INDUCTION BY IFNG.
RX   PubMed=15908954; DOI=10.1038/ni1208;
RA   Saveanu L., Carroll O., Lindo V., Del Val M., Lopez D.,
RA   Lepelletier Y., Greer F., Schomburg L., Fruci D., Niedermann G.,
RA   van Endert P.M.;
RT   "Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase
RT   complexes in the endoplasmic reticulum.";
RL   Nat. Immunol. 6:689-697(2005).
RN   [8]
RP   FUNCTION.
RX   PubMed=16286653; DOI=10.1073/pnas.0500721102;
RA   Chang S.-C., Momburg F., Bhutani N., Goldberg A.L.;
RT   "The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC
RT   class I peptides by a 'molecular ruler' mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:17107-17112(2005).
RN   [9]
RP   GENE REGULATION.
RX   PubMed=16585582; DOI=10.4049/jimmunol.176.8.4869;
RA   Fruci D., Ferracuti S., Limongi M.Z., Cunsolo V., Giorda E.,
RA   Fraioli R., Sibilio L., Carroll O., Hattori A., van Endert P.M.,
RA   Giacomini P.;
RT   "Expression of endoplasmic reticulum aminopeptidases in EBV-B cell
RT   lines from healthy donors and in leukemia/lymphoma, carcinoma, and
RT   melanoma cell lines.";
RL   J. Immunol. 176:4869-4879(2006).
RN   [10]
RP   ALTERNATIVE SPLICING.
RX   PubMed=17332242; DOI=10.1182/blood-2006-11-057208;
RA   Pinyol M., Bea S., Pla L., Ribrag V., Bosq J., Rosenwald A., Campo E.,
RA   Jares P.;
RT   "Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-
RT   mediated mRNA decay pathway inhibition and microarray analysis.";
RL   Blood 109:5422-5429(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF 3-960 IN COMPLEX WITH
RP   SUBSTRATE, GLYCOSYLATION AT ASN-85; ASN-219; ASN-405 AND ASN-650,
RP   ACTIVE SITE, ZINC-BINDING SITES, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=22106953; DOI=10.1021/bi201230p;
RA   Birtley J.R., Saridakis E., Stratikos E., Mavridis I.M.;
RT   "The crystal structure of human endoplasmic reticulum aminopeptidase 2
RT   reveals the atomic basis for distinct roles in antigen processing.";
RL   Biochemistry 51:286-295(2012).
CC   -!- FUNCTION: Aminopeptidase that plays a central role in peptide
CC       trimming, a step required for the generation of most HLA class I-
CC       binding peptides. Peptide trimming is essential to customize
CC       longer precursor peptides to fit them to the correct length
CC       required for presentation on MHC class I molecules. Preferentially
CC       hydrolyzes the basic residues Arg and Lys.
CC       {ECO:0000269|PubMed:12799365, ECO:0000269|PubMed:15908954,
CC       ECO:0000269|PubMed:16286653}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Heterodimer with ERAP1. {ECO:0000269|PubMed:15908954,
CC       ECO:0000269|PubMed:22106953}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12799365}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:12799365}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6P179-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6P179-2; Sequence=VSP_030674, VSP_030675;
CC       Name=3;
CC         IsoId=Q6P179-3; Sequence=VSP_030671;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q6P179-4; Sequence=VSP_030672, VSP_030673;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in
CC       spleen and leukocytes. {ECO:0000269|PubMed:12799365}.
CC   -!- INDUCTION: By IFNG/IFN-gamma. {ECO:0000269|PubMed:15691326,
CC       ECO:0000269|PubMed:15908954}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12799365,
CC       ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:22106953}.
CC   -!- MISCELLANEOUS: Defects in the expression of this gene may cause
CC       improper antigen processing, possibly leading to favor tumor
CC       escape from the immune surveillance.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB109031; BAC78818.1; -; mRNA.
DR   EMBL; AB163917; BAD90015.1; -; mRNA.
DR   EMBL; AY028805; AAK37776.1; -; mRNA.
DR   EMBL; AF191545; AAG28383.1; -; mRNA.
DR   EMBL; CH471084; EAW96080.1; -; Genomic_DNA.
DR   EMBL; BC065240; AAH65240.1; -; mRNA.
DR   EMBL; BC017927; AAH17927.1; -; mRNA.
DR   CCDS; CCDS4086.1; -. [Q6P179-1]
DR   RefSeq; NP_001123612.1; NM_001130140.1. [Q6P179-1]
DR   RefSeq; NP_071745.1; NM_022350.3. [Q6P179-1]
DR   UniGene; Hs.482910; -.
DR   PDB; 3SE6; X-ray; 3.08 A; A/B=1-960.
DR   PDB; 4E36; X-ray; 3.22 A; A/B=1-960.
DR   PDB; 4JBS; X-ray; 2.79 A; A/B=3-960.
DR   PDBsum; 3SE6; -.
DR   PDBsum; 4E36; -.
DR   PDBsum; 4JBS; -.
DR   ProteinModelPortal; Q6P179; -.
DR   SMR; Q6P179; 54-960.
DR   IntAct; Q6P179; 1.
DR   STRING; 9606.ENSP00000342447; -.
DR   BindingDB; Q6P179; -.
DR   ChEMBL; CHEMBL5043; -.
DR   MEROPS; M01.024; -.
DR   PhosphoSite; Q6P179; -.
DR   DMDM; 166232401; -.
DR   MaxQB; Q6P179; -.
DR   PaxDb; Q6P179; -.
DR   PeptideAtlas; Q6P179; -.
DR   PRIDE; Q6P179; -.
DR   Ensembl; ENST00000379904; ENSP00000369235; ENSG00000164308. [Q6P179-3]
DR   Ensembl; ENST00000437043; ENSP00000400376; ENSG00000164308. [Q6P179-1]
DR   Ensembl; ENST00000510309; ENSP00000425758; ENSG00000164308. [Q6P179-4]
DR   Ensembl; ENST00000513084; ENSP00000421849; ENSG00000164308. [Q6P179-2]
DR   GeneID; 64167; -.
DR   KEGG; hsa:64167; -.
DR   UCSC; uc003kmq.3; human. [Q6P179-1]
DR   UCSC; uc003kms.3; human. [Q6P179-3]
DR   CTD; 64167; -.
DR   GeneCards; GC05P096211; -.
DR   H-InvDB; HIX0005053; -.
DR   HGNC; HGNC:29499; ERAP2.
DR   HPA; CAB025618; -.
DR   HPA; HPA034498; -.
DR   MIM; 609497; gene.
DR   neXtProt; NX_Q6P179; -.
DR   PharmGKB; PA162385208; -.
DR   eggNOG; COG0308; -.
DR   GeneTree; ENSGT00760000119082; -.
DR   HOGENOM; HOG000106482; -.
DR   HOVERGEN; HBG108296; -.
DR   InParanoid; Q6P179; -.
DR   KO; K13723; -.
DR   OMA; NVDSNGY; -.
DR   OrthoDB; EOG754HNR; -.
DR   PhylomeDB; Q6P179; -.
DR   TreeFam; TF300395; -.
DR   Reactome; REACT_75795; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   SABIO-RK; Q6P179; -.
DR   GenomeRNAi; 64167; -.
DR   NextBio; 66072; -.
DR   PRO; PR:Q6P179; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; Q6P179; -.
DR   CleanEx; HS_ERAP2; -.
DR   ExpressionAtlas; Q6P179; baseline and differential.
DR   Genevestigator; Q6P179; -.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:HGNC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004177; F:aminopeptidase activity; IDA:HGNC.
DR   GO; GO:0008237; F:metallopeptidase activity; IDA:HGNC.
DR   GO; GO:0008270; F:zinc ion binding; TAS:HGNC.
DR   GO; GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; TAS:HGNC.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0008217; P:regulation of blood pressure; TAS:HGNC.
DR   InterPro; IPR024571; ERAP1-like_C_dom.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR014782; Peptidase_M1_N.
DR   PANTHER; PTHR11533; PTHR11533; 1.
DR   Pfam; PF11838; ERAP1_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Aminopeptidase;
KW   Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Hydrolase; Immunity; Membrane; Metal-binding;
KW   Metalloprotease; Polymorphism; Protease; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN         1    960       Endoplasmic reticulum aminopeptidase 2.
FT                                /FTId=PRO_0000315719.
FT   TOPO_DOM      1     20       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     21     40       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     41    960       Lumenal. {ECO:0000255}.
FT   REGION      334    338       Substrate binding.
FT   ACT_SITE    371    371       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095,
FT                                ECO:0000269|PubMed:22106953}.
FT   METAL       370    370       Zinc; catalytic.
FT   METAL       374    374       Zinc; catalytic.
FT   METAL       393    393       Zinc; catalytic.
FT   BINDING     200    200       Substrate. {ECO:0000269|PubMed:22106953}.
FT   SITE        455    455       Transition state stabilizer.
FT   CARBOHYD     85     85       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:22106953}.
FT   CARBOHYD    119    119       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    405    405       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:22106953}.
FT   CARBOHYD    650    650       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:22106953}.
FT   DISULFID    421    460       {ECO:0000269|PubMed:22106953}.
FT   DISULFID    759    766       {ECO:0000269|PubMed:22106953}.
FT   VAR_SEQ     238    282       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030671.
FT   VAR_SEQ     324    350       DLIAIPDFAPGAMENWGLITYRETSLL -> GMFKFHIIVF
FT                                IFAHKTCFDLFPLSLSM (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030672.
FT   VAR_SEQ     351    960       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030673.
FT   VAR_SEQ     525    532       LAFLGENA -> VRIKRVTE (in isoform 2).
FT                                {ECO:0000303|PubMed:15691326}.
FT                                /FTId=VSP_030674.
FT   VAR_SEQ     533    960       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15691326}.
FT                                /FTId=VSP_030675.
FT   VARIANT     214    214       P -> L (in dbSNP:rs3733905).
FT                                /FTId=VAR_038285.
FT   VARIANT     392    392       K -> N (in dbSNP:rs2549782).
FT                                {ECO:0000269|PubMed:12799365,
FT                                ECO:0000269|PubMed:15691326}.
FT                                /FTId=VAR_038286.
FT   VARIANT     411    411       L -> R (in dbSNP:rs34261036).
FT                                /FTId=VAR_051569.
FT   VARIANT     669    669       L -> Q (in dbSNP:rs17408150).
FT                                /FTId=VAR_038287.
FT   CONFLICT    129    129       R -> K (in Ref. 5; AAH17927).
FT                                {ECO:0000305}.
FT   STRAND       57     60       {ECO:0000244|PDB:4JBS}.
FT   STRAND       66     68       {ECO:0000244|PDB:4E36}.
FT   STRAND       71     85       {ECO:0000244|PDB:4JBS}.
FT   TURN         86     89       {ECO:0000244|PDB:4JBS}.
FT   STRAND       90    103       {ECO:0000244|PDB:4JBS}.
FT   STRAND      106    111       {ECO:0000244|PDB:4JBS}.
FT   STRAND      116    124       {ECO:0000244|PDB:4JBS}.
FT   STRAND      138    142       {ECO:0000244|PDB:4JBS}.
FT   HELIX       143    145       {ECO:0000244|PDB:4JBS}.
FT   STRAND      147    151       {ECO:0000244|PDB:4JBS}.
FT   STRAND      161    171       {ECO:0000244|PDB:4JBS}.
FT   STRAND      173    185       {ECO:0000244|PDB:4JBS}.
FT   STRAND      191    198       {ECO:0000244|PDB:4JBS}.
FT   TURN        200    203       {ECO:0000244|PDB:4JBS}.
FT   HELIX       204    206       {ECO:0000244|PDB:4JBS}.
FT   STRAND      218    226       {ECO:0000244|PDB:4JBS}.
FT   STRAND      231    236       {ECO:0000244|PDB:4JBS}.
FT   STRAND      238    243       {ECO:0000244|PDB:4JBS}.
FT   STRAND      249    253       {ECO:0000244|PDB:4JBS}.
FT   HELIX       261    263       {ECO:0000244|PDB:4JBS}.
FT   STRAND      266    269       {ECO:0000244|PDB:4JBS}.
FT   STRAND      272    277       {ECO:0000244|PDB:4JBS}.
FT   STRAND      283    288       {ECO:0000244|PDB:4JBS}.
FT   HELIX       290    296       {ECO:0000244|PDB:4JBS}.
FT   HELIX       297    314       {ECO:0000244|PDB:4JBS}.
FT   STRAND      319    330       {ECO:0000244|PDB:4JBS}.
FT   STRAND      332    336       {ECO:0000244|PDB:4JBS}.
FT   STRAND      341    345       {ECO:0000244|PDB:4JBS}.
FT   HELIX       346    349       {ECO:0000244|PDB:4JBS}.
FT   TURN        353    355       {ECO:0000244|PDB:4JBS}.
FT   HELIX       358    376       {ECO:0000244|PDB:4JBS}.
FT   TURN        378    380       {ECO:0000244|PDB:4JBS}.
FT   STRAND      381    385       {ECO:0000244|PDB:4JBS}.
FT   HELIX       386    389       {ECO:0000244|PDB:4JBS}.
FT   HELIX       390    407       {ECO:0000244|PDB:4JBS}.
FT   HELIX       409    411       {ECO:0000244|PDB:4JBS}.
FT   HELIX       413    417       {ECO:0000244|PDB:4JBS}.
FT   HELIX       418    428       {ECO:0000244|PDB:4JBS}.
FT   HELIX       443    447       {ECO:0000244|PDB:4JBS}.
FT   TURN        452    455       {ECO:0000244|PDB:4JBS}.
FT   HELIX       456    469       {ECO:0000244|PDB:4JBS}.
FT   HELIX       471    484       {ECO:0000244|PDB:4JBS}.
FT   TURN        485    487       {ECO:0000244|PDB:4JBS}.
FT   STRAND      488    490       {ECO:0000244|PDB:4JBS}.
FT   HELIX       492    500       {ECO:0000244|PDB:4JBS}.
FT   HELIX       534    543       {ECO:0000244|PDB:4JBS}.
FT   STRAND      548    555       {ECO:0000244|PDB:4JBS}.
FT   STRAND      558    565       {ECO:0000244|PDB:4JBS}.
FT   STRAND      590    592       {ECO:0000244|PDB:4JBS}.
FT   STRAND      594    596       {ECO:0000244|PDB:4JBS}.
FT   STRAND      601    603       {ECO:0000244|PDB:4JBS}.
FT   STRAND      607    613       {ECO:0000244|PDB:4JBS}.
FT   STRAND      621    624       {ECO:0000244|PDB:3SE6}.
FT   HELIX       625    627       {ECO:0000244|PDB:4JBS}.
FT   STRAND      632    636       {ECO:0000244|PDB:4JBS}.
FT   HELIX       639    648       {ECO:0000244|PDB:4JBS}.
FT   HELIX       651    653       {ECO:0000244|PDB:4JBS}.
FT   HELIX       656    670       {ECO:0000244|PDB:4JBS}.
FT   TURN        671    673       {ECO:0000244|PDB:4JBS}.
FT   HELIX       677    681       {ECO:0000244|PDB:4JBS}.
FT   TURN        682    685       {ECO:0000244|PDB:4JBS}.
FT   HELIX       686    688       {ECO:0000244|PDB:4JBS}.
FT   HELIX       693    712       {ECO:0000244|PDB:4JBS}.
FT   HELIX       716    728       {ECO:0000244|PDB:4JBS}.
FT   HELIX       731    735       {ECO:0000244|PDB:4JBS}.
FT   HELIX       745    760       {ECO:0000244|PDB:4JBS}.
FT   HELIX       764    780       {ECO:0000244|PDB:4JBS}.
FT   HELIX       788    798       {ECO:0000244|PDB:4JBS}.
FT   HELIX       802    812       {ECO:0000244|PDB:4JBS}.
FT   HELIX       818    829       {ECO:0000244|PDB:4JBS}.
FT   HELIX       834    846       {ECO:0000244|PDB:4JBS}.
FT   STRAND      848    850       {ECO:0000244|PDB:4JBS}.
FT   HELIX       852    854       {ECO:0000244|PDB:4JBS}.
FT   HELIX       855    864       {ECO:0000244|PDB:4JBS}.
FT   HELIX       866    878       {ECO:0000244|PDB:4JBS}.
FT   HELIX       880    886       {ECO:0000244|PDB:4JBS}.
FT   HELIX       892    902       {ECO:0000244|PDB:4JBS}.
FT   HELIX       908    920       {ECO:0000244|PDB:4JBS}.
FT   STRAND      923    925       {ECO:0000244|PDB:4JBS}.
FT   HELIX       930    959       {ECO:0000244|PDB:4JBS}.
SQ   SEQUENCE   960 AA;  110462 MW;  261EFC06870D644E CRC64;
     MFHSSAMVNS HRKPMFNIHR GFYCLTAILP QICICSQFSV PSSYHFTEDP GAFPVATNGE
     RFPWQELRLP SVVIPLHYDL FVHPNLTSLD FVASEKIEVL VSNATQFIIL HSKDLEITNA
     TLQSEEDSRY MKPGKELKVL SYPAHEQIAL LVPEKLTPHL KYYVAMDFQA KLGDGFEGFY
     KSTYRTLGGE TRILAVTDFE PTQARMAFPC FDEPLFKANF SIKIRRESRH IALSNMPKVK
     TIELEGGLLE DHFETTVKMS TYLVAYIVCD FHSLSGFTSS GVKVSIYASP DKRNQTHYAL
     QASLKLLDFY EKYFDIYYPL SKLDLIAIPD FAPGAMENWG LITYRETSLL FDPKTSSASD
     KLWVTRVIAH ELAHQWFGNL VTMEWWNDIW LKEGFAKYME LIAVNATYPE LQFDDYFLNV
     CFEVITKDSL NSSRPISKPA ETPTQIQEMF DEVSYNKGAC ILNMLKDFLG EEKFQKGIIQ
     YLKKFSYRNA KNDDLWSSLS NSCLESDFTS GGVCHSDPKM TSNMLAFLGE NAEVKEMMTT
     WTLQKGIPLL VVKQDGCSLR LQQERFLQGV FQEDPEWRAL QERYLWHIPL TYSTSSSNVI
     HRHILKSKTD TLDLPEKTSW VKFNVDSNGY YIVHYEGHGW DQLITQLNQN HTLLRPKDRV
     GLIHDVFQLV GAGRLTLDKA LDMTYYLQHE TSSPALLEGL SYLESFYHMM DRRNISDISE
     NLKRYLLQYF KPVIDRQSWS DKGSVWDRML RSALLKLACD LNHAPCIQKA AELFSQWMES
     SGKLNIPTDV LKIVYSVGAQ TTAGWNYLLE QYELSMSSAE QNKILYALST SKHQEKLLKL
     IELGMEGKVI KTQNLAALLH AIARRPKGQQ LAWDFVRENW THLLKKFDLG SYDIRMIISG
     TTAHFSSKDK LQEVKLFFES LEAQGSHLDI FQTVLETITK NIKWLEKNLP TLRTWLMVNT
//
